by Corinne Gangloff
February 2, 2022
Cleveland OH, February 2, 2022 – A new Freedonia Group analysis projects global demand for vaccine packaging to rise nearly 7% annually through 2025 to $3.6 billion, boosted by pandemic-driven increases in vaccine production and expanding use of higher value vaccine packaging systems with enhanced barrier, safety, and ease-of-use features:
Western Europe generates the most demand for vaccine packaging among global regions, reflecting the production activities of companies such as BioNTech, GlaxoSmithKline, Sanofi, and Pfizer. Asia/Pacific holds the second largest share of global demand, with China, Japan, and India dividing the majority of sales:
Led by U.S.-based vaccine makers Merck & Company and Pfizer, North America is the third largest regional consumer of vaccine packaging. Demand for this packaging in other regions is limited, although Russia has emerged as a major competitor in COVID-19 vaccines and Brazil’s Fiocruz produces several vaccines against common diseases widely prevalent in the developing countries.
Want to Learn More?
Global Vaccine Packaging, now available from The Freedonia Group, presents historical data (2010, 2015, and 2020) and forecasts for 2025 and 2030 for vaccine packaging demand by global region and country. Among the specific products covered are:
Provide the following details to subscribe.